SANTINOLI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 440
EU - Europa 342
AS - Asia 222
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 1.011
Nazione #
US - Stati Uniti d'America 437
CN - Cina 134
IE - Irlanda 72
IT - Italia 61
SG - Singapore 53
DE - Germania 49
SE - Svezia 44
AT - Austria 41
FI - Finlandia 38
TR - Turchia 17
JP - Giappone 11
BE - Belgio 8
GB - Regno Unito 8
UA - Ucraina 6
ES - Italia 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
CA - Canada 3
IN - India 3
EU - Europa 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
BR - Brasile 1
LT - Lituania 1
LU - Lussemburgo 1
NG - Nigeria 1
PT - Portogallo 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.011
Città #
Chandler 112
Dublin 72
Singapore 48
Ashburn 46
Dearborn 41
Vienna 41
Parma 39
Ann Arbor 29
New York 24
Shanghai 22
Nanjing 21
Izmir 17
Boardman 14
Bremen 14
Princeton 14
Shenyang 12
Beijing 11
Jinan 11
Nakano 11
Brussels 8
Grafing 8
Wilmington 8
Hebei 7
Nanchang 6
Seattle 6
Munich 5
Changsha 4
Jacksonville 4
Jakarta 4
Lugo 4
Washington 4
Dallas 3
Düsseldorf 3
Hefei 3
Norwalk 3
San Mateo 3
Scottsdale 3
Tianjin 3
Toronto 3
Bengaluru 2
Borås 2
Bílovice nad Svitavou 2
Fitzherbert 2
Fremont 2
Helsinki 2
Jiaxing 2
Kunming 2
Los Angeles 2
Ningbo 2
Santa Clara 2
Shaoxing 2
Wuhan 2
Zhengzhou 2
Abano Terme 1
Belo Horizonte 1
Budapest 1
Cadelbosco 1
Castelnuovo 1
Chengdu 1
Frankfurt am Main 1
Genova 1
Guangzhou 1
Haikou 1
Houston 1
Huzhou 1
Johannesburg 1
Langfang 1
Lanzhou 1
Leipzig 1
London 1
Luxembourg 1
Madrid 1
Magdeburg 1
Maser 1
Milan 1
Nagold 1
Port Harcourt 1
Redmond 1
Reggio Emilia 1
Reggio Nell'emilia 1
Rockville 1
Vicenza 1
Woodbridge 1
Xian 1
Zhongxin 1
Totale 751
Nome #
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 103
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 96
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 94
Antibodies as a source of anti-infective peptides: an update 89
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 78
Peptides from the inside of the antibodies are active against infectious agents and tumours 77
Natural and synthetic peptides with antifungal activity 75
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 73
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 67
Mode of action of a killer peptide against Toxoplasma gondii 65
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 62
In vitro and in vivo anticandidal activity of killer peptide derivatives 56
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 55
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 51
Totale 1.041
Categoria #
all - tutte 3.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 15 32 25 9 1 33 2 0
2020/202130 0 4 5 2 4 1 2 1 6 0 2 3
2021/202250 2 0 0 2 0 8 0 8 6 4 3 17
2022/2023362 32 39 22 37 39 53 2 29 97 0 3 9
2023/2024145 12 13 6 2 13 54 5 6 6 5 8 15
2024/2025102 16 18 16 34 18 0 0 0 0 0 0 0
Totale 1.041